Cannabix Technologies (BLOZF) Stock Price, News & Analysis

Company Overview

Cannabix Technologies Inc. is a Canada-based developer of bio­sensor technologies focused on the rapid, non-invasive detection of cannabis impairment. The company’s flagship product is a handheld breathalyzer device designed to identify recent use of tetrahydrocannabinol (THC) within minutes of exhalation, offering law enforcement agencies, public safety organizations and workplace safety departments a potential tool to assess impairment in real time.

The Cannabix breathalyzer employs proprietary sensor arrays and on-board algorithms to distinguish THC molecules in breath samples, delivering results without the need for laboratory analysis. In addition to its cannabis detection platform, the company is exploring integration of alcohol and multi-drug screening capabilities to create a more comprehensive roadside and occupational testing solution. Cannabix has pursued partnerships with research institutions and regulatory bodies to validate its technology under controlled conditions.

Headquartered in Vancouver, British Columbia, Cannabix Technologies conducts its research and development activities at its Canadian laboratories and collaborates with external contract manufacturers for product assembly. The company’s management team is led by Chief Executive Officer Craig Ellins, who brings experience in technology commercialization and regulatory affairs. The board and executive suite also include professionals with backgrounds in biosensor engineering, public safety and diagnostics marketing.

As a publicly traded entity on the OTC Markets under the symbol BLOZF, Cannabix Technologies continues to advance its prototype toward regulatory approval and commercial rollout. Its primary markets include North America and select international jurisdictions considering roadside and workplace drug screening solutions, with ongoing efforts to secure government contracts and private-sector distribution agreements.

Key Stats

• Today's Range: $0.39 to $0.41
• 50-Day Range: $0.38 to $0.47
• 52-Week Range: $0.20 to $0.50
• Volume: 47,964 shs
• Average Volume: 78,154 shs
• Market Capitalization: $49.03 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BLOZF Stock Analysis - Frequently Asked Questions

How have BLOZF shares performed this year?

Cannabix Technologies' stock was trading at $0.2337 at the beginning of the year. Since then, BLOZF shares have increased by 73.3% and is now trading at $0.4050.

How were Cannabix Technologies' earnings last quarter?

Cannabix Technologies Inc. (OTCMKTS:BLOZF) announced its quarterly earnings results on Thursday, August, 28th. The company reported ($0.01) EPS for the quarter.

How do I buy shares of Cannabix Technologies?

Shares of BLOZF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 8/28/2025
• Today: 9/21/2025
• Fiscal Year End: 4/30/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Business Services
• Industry: Technology Services
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:BLOZF
• CIK: N/A
• Web: www.cannabixtechnologies.com
• Phone: 604-551-7831
• Fax: 604-676-2767
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.02)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$3.36 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -142.40%
• Return on Assets: -132.23%

Debt

• Debt-to-Equity Ratio: 0.01
• Current Ratio: 6.20
• Quick Ratio: 6.20

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.02 per share
• Price / Book: 20.25

Miscellaneous

• Outstanding Shares: 121,070,000
• Free Float: N/A
• Market Cap: $49.03 million
• Optionable: Not Optionable
• Beta: 1.89